Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
Qualitative study assessing cancer-related fatigue during maintenance immunotherapy for non-small cell lung cancer in a clinical trial setti…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer [Phase 3]
A Phase III clinical trial is evaluating HB0025 plus chemotherapy versus tislelizumab plus chemotherapy as first-line therapy for advanced n…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study of EP0031 in Patients With Advanced RET-altered Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for EP0031 in patients with advanced RET-altered malignancies, including non-small cell lung cancer, which…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial sponsored by GlaxoSmithKline evaluating PD-L1 response using extracellular vesicles, patient-derived organo…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Lung Cancer Screening in Population Who Had Never Smoked [NA]
A clinical trial update describing a study on lung cancer screening in people who have never smoked; the trial is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study [NA]
The PERCC study is currently recruiting participants with non-small cell lung cancer (stage II and stage III) to evaluate a precision exerci…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a 3D virtual reality planning approach combined with indocyanine green fluorescence mapping to guide t…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating SFRT plus tislelizumab and platinum-based chemotherapy for unresectable stage III non-small cell lung …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating near-infrared fluorescence guided robotic pulmonary segmentectomy for early-stage non-small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC [NA]
A clinical trial comparing totally robotic versus surgeon-assisted robotic lung resection for early-stage non-small cell lung cancer; the st…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Synapse 3D With Intravascular Indocyanine Green [Phase 1, Phase 2]
This update notes a Phase 1/2 trial of Synapse 3D with intravascular indocyanine green that is currently recruiting for non-small cell lung …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]
First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
This document reports an observational emulation of the FLAURA trial for first-line treatment in non-small cell lung cancer using specialty …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update comparing zimberelimab plus domvanalimab with chemotherapy versus pembrolizumab with chemotherapy in patients with untr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade [Phase 2]
A Phase 2 clinical trial is evaluating a triple combination of docetaxel, ramucirumab, and pembrolizumab for metastatic or recurrent non-sma…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLC [NA]
Clinical trials.gov reports an update on a study evaluating SHR-A1811 in combination with pertuzumab as second-line therapy for HER2-altered…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer [NA]
This clinical trial update notes that recruitment is ongoing for a study testing adaptive radiation planning to reduce radiation-induced tox…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
An AstraZeneca-sponsored clinical trial update for a quality improvement study aimed at improving lung cancer care in small and middle-tier …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: IMPT Dose Escalation for NSCLC (HyDose) [NA]
Clinical trial update for HyDose, a dose-escalation study of IMPT in non-small cell lung cancer. It is currently recruiting at University Me…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update for a study comparing Uliledlimab plus Toripalimab, Toripalimab monotherapy, and Pembrolizumab monotherapy in previous…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. [Phase 1, Phase 2]
Phase 1/2a trial evaluating WEF-001 as monotherapy for safety, tolerability, pharmacokinetics, and preliminary efficacy in advanced KRAS-mut…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
This study is recruiting to evaluate Iruplinalkib in ALK-positive advanced non-small cell lung cancer after progression on Lorlatinib, incor…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TGI-5 as a monotherapy and in combination with nivolumab in locally advanced or metastatic solid tumors; recruiting…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating subcutaneous atezolizumab for non-small cell lung cancer, sponsored by the University of Souther…